ORAI1 and breast carcinoma: As the effects of these novel compounds were investigated on native SOC of breast cancer cells (MDA-MB-231) and HEK 293 cells, their effects on Orai1 and Orai3 individually remain of interest to determine potential isoform-specificity [134].